GE, Cardinal Say Imaging Drug Antitrust Claims Lack Specifics

Law360, New York (November 14, 2012, 1:54 PM EST) -- GE Healthcare Inc. and Cardinal Health Inc. urged a California federal court Tuesday to toss a radiopharmacy owner's putative antitrust class action, saying the suit failed to specifically allege a plausible anti-competitive conspiracy, a problem that doomed an earlier version of the complaint.

In separate motions to dismiss, GE and Cardinal both said that a second amended complaint filed by radiopharmacy owner PharmaRx Pharmaceutical Inc. — which alleges that a distribution deal between GE and Cardinal on cardiac imaging agents violated antitrust laws — suffered from...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.